ETON — Eton Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- $89.92m
- $78.28m
- $31.64m
- 65
- 24
- 34
- 36
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -18.3 | -28 | -1.96 | -9.02 | -0.936 |
Depreciation | |||||
Non-Cash Items | 1.9 | 3.96 | 2.98 | 4.34 | 3.25 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.06 | 1.01 | -6.21 | 7.72 | 3.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -18 | -22.3 | -4.72 | 4.82 | 6.82 |
Capital Expenditures | -1.85 | -0.05 | -3.26 | -2.79 | -0.775 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | 0.7 | 0 | 0 |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -1.85 | -0.05 | -2.56 | -2.79 | -0.775 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.2 | 31.6 | 0.391 | -0.134 | -0.957 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -14.7 | 9.23 | -6.89 | 1.9 | 5.08 |